ViewRay holds the exclusive worldwide license from the University of Florida for this technology, for the life of the patent. ViewRay's founder and Chief Scientific Officer, James F. Dempsey, Ph.D., is the inventor of the Renaissance™ System, and is now devoting his attention exclusively to the further development of this product.
Mindful of a pressing patient need, Dr. Dempsey promptly joined with seasoned business executives to formally advance the Renaissance™ System 1000 from concept to patient readiness. Together, the ViewRay team is focusing on the development activities necessary to quickly, but methodically and safely, make the Renaissance™ System 1000 available to cancer patients worldwide.
